FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new peptide compounds, pharmaceutical compositions containing them, application of said compound for making a drug exhibiting activity with respect to hV1a receptor for treating related conditions, particularly depressed cases. The compounds are presented by general formula 
(I) which is specified in the description of the invention.
EFFECT: preparation of new peptide compounds.
12 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE AGONISTS OF VASOPRESSIN RECEPTOR | 2005 |
|
RU2355701C2 |
| V1A-RECEPTORS AGONISTS | 2013 |
|
RU2634617C2 |
| OXYTOCIN ANALOGUES | 2009 |
|
RU2496788C2 |
| PRODRUG CONTAINING A SELF-CLEAVABLE LINKER | 2018 |
|
RU2798085C2 |
| PRODRUG CONTAINING SELF-CLEAVABLE LINKER | 2014 |
|
RU2676324C2 |
| OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
| CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
| NOVEL METHODS OF PRODUCING BARUSIBAN AND INTERMEDIATE COMPOUNDS THEREOF | 2016 |
|
RU2726414C2 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| NEW OCTAPEPTIDE COMPOUNDS AND THEIR THERAPEUTIC APPLICATION | 2011 |
|
RU2595525C2 |
